Skip to main content Accessibility help
×
Hostname: page-component-cd9895bd7-lnqnp Total loading time: 0 Render date: 2024-12-22T23:47:14.202Z Has data issue: false hasContentIssue false

16 - New antiviral screening assays

Published online by Cambridge University Press:  27 August 2009

Mark A. Feitelson
Affiliation:
Thomas Jefferson University, Philadelphia
Get access

Summary

The lack of tissue culture systems that consistently support HCV replication (Ch. 11) has prompted the development of other assays with individual virus gene products that may be converted into high throughput screens for drug screening and discovery. A powerful tool in the design of such assays has been the development of cell lines and cell-free systems that express one or more HCV proteins (Table 11.1). For example, the recent development of HCV subgenomic replicons in Huh7 cells provides opportunities to test antiviral compounds against the virus polymerase, which is responsible for the replication of the subgenomic plasmids in this system (Lohmann et al., 1999; Blight et al., 2000). In addition, the development of cell lines or chimeric viruses with replication dependent upon HCV NS3 expression (Hirowatari, Hijikata & Shimotohno, 1995; Hahm et al., 1996; Song et al., 1996; Filocamo, Pacini & Migliaccio, 1997) will allow screening against the NS3 protease and helicase. Another important contribution has been the publication of the crystal structure for several HCV proteins. This information will be central to the rational design of inhibitors based upon the three-dimensional active sites of the corresponding virus proteins. For example, the recent crystallographic structure of the NS3 helicase domain (Yao & Weber, 1998; Kwong, Kim & Lin, 2000) (Sections 2.4 and 2.5), which recognizes and unwinds double-stranded RNA in an NTP-dependent reaction during virus replication, has revealed amino acid residues that could be sites for inhibitor design and interaction.

Type
Chapter
Information
Hepatitis C Virus
From Laboratory to Clinic
, pp. 131 - 134
Publisher: Cambridge University Press
Print publication year: 2002

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×